Thomas B. Marriott
Keine laufenden Positionen mehr
Profil
Thomas B.
Marriott III has been Vice President of Development Research for NPS Pharmaceuticals, Inc. since August 1993.
Previously, he served as Director of Clinical Investigations for McNeil Pharmaceutical from February 1990 to July 1993 and as Director of Drug Metabolism from 1986 to 1990.
Dr. Marriott received a PhD in Chemistry from the University of Oregon.
Ehemalige bekannte Positionen von Thomas B. Marriott
| Unternehmen | Position | Ende |
|---|---|---|
| McNeil Pharmaceutical | Corporate Officer/Principal | 01.07.1993 |
ZARS Pharma, Inc.
 ZARS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZARS Pharma, Inc. develops and distributes drugs. It is a specialty pharmaceutical company focused on the development and commercialization of topically administered drugs, primarily for the treatment of pain, using its proprietary drug delivery technologies. The company was founded by Jie Zhang, Theodore H. Stanley, Larry D. Rigby and Michael A. Ashburn in 1996 and is headquartered in Salt Lake City, UT. | General Counsel | - |
| NPS PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Thomas B. Marriott
| Carleton College | Undergraduate Degree |
| University of Oregon | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
ZARS Pharma, Inc.
ZARS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZARS Pharma, Inc. develops and distributes drugs. It is a specialty pharmaceutical company focused on the development and commercialization of topically administered drugs, primarily for the treatment of pain, using its proprietary drug delivery technologies. The company was founded by Jie Zhang, Theodore H. Stanley, Larry D. Rigby and Michael A. Ashburn in 1996 and is headquartered in Salt Lake City, UT. | Health Technology |
| McNeil Pharmaceutical |
